Tinofolin® by Sabinsa Corporation
Tinofolin® by Sabinsa Corporation
Tinofolin® by Sabinsa Corporation is a proprietary nootropic extract derived from Tinospora cordifolia (Guduchi), standardized to 2.5% bitter principles. This branded ingredient supports applications in cognitive health, particularly memory, attention, and concentration. Clinical studies show safety at 500 mg daily with no significant adverse effects. Developed with Sabinsa’s patented processes, Tinofolin® provides manufacturers and formulators with a validated Ayurvedic-derived solution for enhancing verbal learning, logical memory, and overall cognitive performance.
0.0 out of 5 stars (based on 0 endorsements)
General
Item #:
Company:
Sabinsa Corporation
Technology:
Proprietary extract of Tinospora cordifolia
Name:
Tinofolin®
Ingredient/s:
Bitter principles
Categories:
Brain health, Cognitive health, Nootropic, Concentration
Dosage (min):
Dosage (max):
500 mg
Price kg:
MOQ:
Botanical Names:
Tinospora cordifolia
Active/s:
Bitter principles
Assay:
Standardized to 2.5% bitter principles
Country of Origin:
Suppliers:
Sabinsa Corporation
Contact Information
Email:
VISIT WEBSITE
Documents (Coming Soon)
Upgrade your account to access documents
COMING SOON
Ingredient Overview
Cheat Sheet Card
100% Natural
Vegan
Gluten Free
Non-GMO
GRAS
Water Soluble
Wild-Harvested
Allergen Free
Key Certifications
Halal Certified
Kosher Certified
Vegan Certified
USDA Organic
NON-GMO Project Verified
Gluten-Free Certified
Send an Inquiry
Featured Ingredients
Ingredient Highlights
Tinofolin® features clinically supported actives shown to help:
- Supports memory performance and verbal recall speed.*
- Promotes attention span and cognitive focus.*
- Improves logical memory in healthy individuals.*
- Enhances executive function and mental clarity.*
- Supports overall cognitive processing in adults.*
- Promotes learning and information retention capacity.*
Featured Content
Product type
Related Articles
Endorsement
0.0 out of 5 stars (based on 0 endorsements)
There are no reviews yet. Be the first one to write one.
